Importantly, the inflammation score of the sLNP‐OVA/Cel group was significantly lower than that of the sLNP‐OVA group (Figure S6F, Supporting Information), indicating the potent therapeutic effects of sLNP‐OVA/Cel against experimental allergic asthma. Here, CEL is linked to allergic asthma.